The burden of chronic respiratory disease and attributable risk factors in North Africa and Middle East: findings from global burden of disease study (GBD) 2019.
Burden
Chronic respiratory disease
DALYs
GBD
North Africa and Middle East
Journal
Respiratory research
ISSN: 1465-993X
Titre abrégé: Respir Res
Pays: England
ID NLM: 101090633
Informations de publication
Date de publication:
29 Sep 2022
29 Sep 2022
Historique:
received:
11
04
2022
accepted:
19
09
2022
entrez:
29
9
2022
pubmed:
30
9
2022
medline:
4
10
2022
Statut:
epublish
Résumé
North Africa and Middle East (NAME) has an increasing burden of chronic respiratory diseases (CRDs); however, a systematic understanding of the distribution and trends is not available. We aimed to report the trends of CRDs and attributable risk factors in this region between 1990 and 2019. Using data from the Global Burden of Diseases Study (GBD) 2019, cause specific mortality served as the basis for estimating incidence and disability-adjusted life years (DALYs). The burden attributable to risk factors was calculated by a comparative risk assessment and contribution of population ageing and growth was determined by decomposition analysis. The number of deaths due to CRD in 2019 were 128,513 (110,781 to 114,351). In 2019, the age-standardized incidence rate (ASIR) of CRDs was 1052.8 (924.3 to 1209.4) per 100,000 population and had a 10.3% increase and the age-standardized death rate (ASDR) was 36.1 (30.9 to 40.3) with a 32.9% decrease compared to 1990. In 2019, United Arab Emirates had the highest ASIR (1412.7 [1237.3 to 1622.2]) and Afghanistan had the highest ASDR (67.8 [52.0 to 81.3]). CRDs were responsible for 2.91% of total DALYs in 2019 (1.69% due to chronic obstructive pulmonary disease [COPD] and 1.02% due to asthma). With regard to the components of DALYs, the age-standardized rate of years of life lost (YLL) had a - 39.0% (- 47.1 to - 30.3) decrease; while the age-standardized rate of years lived with disability (YLD) had a 13.4% (9.5 to 17.7) increase. Of total ASDRs of CRDs, 31.6% were attributable to smoking and 14.4% to ambient particulate matter pollution. CRDs remain a leading cause of death and disability in NAME, with growth in absolute numbers. COPD and asthma were the most common CRDs and smoking was the leading risk factor especially in men. More attention is needed in order to reduce CRDs' burden through appropriate interventions and policies.
Sections du résumé
BACKGROUND
BACKGROUND
North Africa and Middle East (NAME) has an increasing burden of chronic respiratory diseases (CRDs); however, a systematic understanding of the distribution and trends is not available. We aimed to report the trends of CRDs and attributable risk factors in this region between 1990 and 2019.
METHODS
METHODS
Using data from the Global Burden of Diseases Study (GBD) 2019, cause specific mortality served as the basis for estimating incidence and disability-adjusted life years (DALYs). The burden attributable to risk factors was calculated by a comparative risk assessment and contribution of population ageing and growth was determined by decomposition analysis.
RESULTS
RESULTS
The number of deaths due to CRD in 2019 were 128,513 (110,781 to 114,351). In 2019, the age-standardized incidence rate (ASIR) of CRDs was 1052.8 (924.3 to 1209.4) per 100,000 population and had a 10.3% increase and the age-standardized death rate (ASDR) was 36.1 (30.9 to 40.3) with a 32.9% decrease compared to 1990. In 2019, United Arab Emirates had the highest ASIR (1412.7 [1237.3 to 1622.2]) and Afghanistan had the highest ASDR (67.8 [52.0 to 81.3]). CRDs were responsible for 2.91% of total DALYs in 2019 (1.69% due to chronic obstructive pulmonary disease [COPD] and 1.02% due to asthma). With regard to the components of DALYs, the age-standardized rate of years of life lost (YLL) had a - 39.0% (- 47.1 to - 30.3) decrease; while the age-standardized rate of years lived with disability (YLD) had a 13.4% (9.5 to 17.7) increase. Of total ASDRs of CRDs, 31.6% were attributable to smoking and 14.4% to ambient particulate matter pollution.
CONCLUSION
CONCLUSIONS
CRDs remain a leading cause of death and disability in NAME, with growth in absolute numbers. COPD and asthma were the most common CRDs and smoking was the leading risk factor especially in men. More attention is needed in order to reduce CRDs' burden through appropriate interventions and policies.
Identifiants
pubmed: 36175873
doi: 10.1186/s12931-022-02187-3
pii: 10.1186/s12931-022-02187-3
pmc: PMC9521864
doi:
Substances chimiques
Particulate Matter
0
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
268Informations de copyright
© 2022. The Author(s).
Références
JAMA Oncol. 2017 Apr 01;3(4):524-548
pubmed: 27918777
Lancet. 2020 Oct 17;396(10258):1223-1249
pubmed: 33069327
Ann Saudi Med. 2022 Jan-Feb;42(1):1-7
pubmed: 35112589
Pediatr Pulmonol. 2014 May;49(5):430-4
pubmed: 24610581
Thorax. 2009 Jun;64(6):476-83
pubmed: 19237391
Respir Med Res. 2020 Nov;78:100764
pubmed: 32498023
Lancet. 2020 Oct 17;396(10258):1204-1222
pubmed: 33069326
J Med Virol. 2020 Jul;92(7):915-918
pubmed: 32270515
Lancet Glob Health. 2020 Jan;8(1):e33-e34
pubmed: 31839137
J Clin Pharmacol. 2021 May;61(5):581-590
pubmed: 33217030
Lancet Respir Med. 2020 Jun;8(6):585-596
pubmed: 32526187
Popul Health Metr. 2012 Jan 06;10:1
pubmed: 22226226
Caspian J Intern Med. 2021 Apr;12(3):356-358
pubmed: 34221288
Front Pediatr. 2019 Jun 18;7:246
pubmed: 31275909
Arch Iran Med. 2020 May 01;23(5):353-355
pubmed: 32383620
Expert Rev Respir Med. 2010 Oct;4(5):593-604
pubmed: 20923339
J Pediatr. 2016 Sep;176:36-42
pubmed: 27318375
MMWR Morb Mortal Wkly Rep. 2020 Jun 12;69(23):693-698
pubmed: 32525855
J Diabetes Metab Disord. 2020 Oct 20;20(1):825-829
pubmed: 34222092
Tob Control. 2004 Dec;13(4):327-33
pubmed: 15564614
Saudi Med J. 2004 Feb;25(2):215-9
pubmed: 14968222
J Thorac Dis. 2017 Nov;9(11):4676-4689
pubmed: 29268538
ERJ Open Res. 2021 Feb 08;7(1):
pubmed: 33575313
Chest. 2015 Oct;148(4):971-985
pubmed: 25950276
J Allergy Clin Immunol. 2018 Apr;141(4):1169-1179
pubmed: 29627041
BMJ. 2020 Feb 19;368:m234
pubmed: 32075787
East Mediterr Health J. 2001 Jul-Sep;7(4-5):819-28
pubmed: 15332785
Occup Environ Med. 2020 Jun;77(6):407-414
pubmed: 32188634
Glob Health Res Policy. 2017 Sep 04;2:25
pubmed: 29202093
Lancet. 2021 Jun 19;397(10292):2337-2360
pubmed: 34051883
Popul Health Metr. 2003 Apr 14;1(1):1
pubmed: 12780936